|
2.
|
First Report of Edge Vascular Response at 12Months of Magmaris, A Second-Generation Drug-Eluting Resorbable Magnesium Scaffold, Assessed by Grayscale Intravascular Ultrasound, Virtual Histology, and Optical Coherence Tomography. A Biosolve-II Trial Sub-Study. MedStar authors:
- Azizi, Viana
- Dan, Kazuhiro
- Garcia-Garcia, Hector M
- Hideo-Kajita, Alexandre
- Kuku, Kayode
- Ozaki, Yuichi
- Waksman, Ron
Year: 2019
Citation: - Cardiovascular Revascularization Medicine. 20(5):392-398, 2019 05.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Azizi V, Christiansen EH, Dan K, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Hideo-Kajita A, Ince H, Joner M, Kaiser C, Koolen J, Kuku KO, Lemos PA, Neumann FJ, Ozaki Y, Teik LS, Toelg R, von Birgelen C, Waksman R, Wijns W
|